Roche Battered By Biosimilars But Holds On To Initial Forecast

Still Expects CHF4.6bn Impact From Biosimilar Competition For 2021

 
• By Dean Rudge
  
Roche
Roche expects Lucentis competition in 2021 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products